Elizabeth Crawford

Elizabeth Crawford is a seasoned professional in business development and commercialization within the medical device and diagnostic sectors. Currently serving as the Senior Business Development Manager at iiCON: Infection Innovation Consortium since May 2023, Elizabeth previously held the position of CEO at Clin-e-cal ltd from January 2017 to August 2023. Prior experience includes roles as Licensing Manager and Commercialisation Executive at UMIP, where Elizabeth focused on developing intellectual property projects and identifying commercially viable opportunities from university research. Elizabeth's career commenced with a research project at Cambridge Antibody Technology as a Sandwich student in the preclinical pharmacology team. Educationally, Elizabeth Crawford holds a PhD in Molecular Biology and a BSc in Pharmacology with Industrial Experience, both from The University of Manchester.